LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT05998330
- Status
- Recruiting
Conditions
- Advanced Cirrhosis
- Cirrhosis
- Cirrhosis, Liver
- End Stage Liver DIsease
- Liver Disease Chronic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- LiverPAL — BEHAVIORALThe intervention include integrating early palliative care with usual hepatology care to evaluate and treat patients' symptoms, enhance their illness and prognostic understanding, support their coping, and coordinate their serious illness, transitional, and end-of-life care.
Study Details
The goal of this clinical trial is to evaluate whether early integration of palliative care in the care of hospitalized patients with advanced liver disease (AdvLD) can improve patients' quality of life, physical symptoms, mood, and serious illness communication. Palliative care is a medical specialty focused on lessening (or "palliating") symptoms and assisting in coping with serious illness.
Key Dates
- Start date
- Sep 20, 2023
- Status verified
- Jul 2025
- Primary completion
- Jul 31, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: Usual Hepatology CareUsual hepatology care
- Experimental: Usual Hepatology Care with Early Palliative CareUsual hepatology care with early palliative care
Primary Outcome Measure
Patient Quality of Life (Functional Assessment of Chronic Illness Therapy - Palliative Care, FACIT-Pal) up t0 4 weeks [ Time Frame: Up to 4 weeks ]
Central Contacts
- Grace Bizup, BA617-724-1316
- William Munroe, BA617- 726-0161
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Nneka N Ufere, MD MSCE (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By research site
Related Studies
- Allogenic Hepatocyte Transplantation Into Periduodenal Lymph NodesPHASE2 · Recruiting · LyGenesis, Inc. · Boston, Massachusetts
- Safety and Efficacy of Atorvastatin v. Placebo on HCC RiskPHASE2 · Recruiting · Raymond Chung · Boston, Massachusetts
- HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver DiseaseRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts